Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
$34.61
+2.1%
$34.02
$14.97
▼
$37.22
$1.34B0.38567,190 shs920,398 shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$33.03
+0.1%
$36.14
$29.06
▼
$55.00
$1.51B0.97573,784 shs499,229 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$120.15
-1.3%
$134.25
$100.18
▼
$145.00
$5.29B0.82681,988 shs869,638 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$374.51
-0.4%
$349.98
$223.83
▼
$386.00
$26.12B1.14549,086 shs715,925 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
-2.42%-3.19%-1.98%+4.08%+83.83%
Omnicell, Inc. stock logo
OMCL
Omnicell
-0.54%+1.73%-4.82%-16.54%+6.42%
Teleflex Incorporated stock logo
TFX
Teleflex
-2.72%-4.78%-11.88%-4.48%-0.10%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
+1.17%+3.63%+6.39%+8.23%+49.66%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
$34.61
+2.1%
$34.02
$14.97
▼
$37.22
$1.34B0.38567,190 shs920,398 shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$33.03
+0.1%
$36.14
$29.06
▼
$55.00
$1.51B0.97573,784 shs499,229 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$120.15
-1.3%
$134.25
$100.18
▼
$145.00
$5.29B0.82681,988 shs869,638 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$374.51
-0.4%
$349.98
$223.83
▼
$386.00
$26.12B1.14549,086 shs715,925 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
-2.42%-3.19%-1.98%+4.08%+83.83%
Omnicell, Inc. stock logo
OMCL
Omnicell
-0.54%+1.73%-4.82%-16.54%+6.42%
Teleflex Incorporated stock logo
TFX
Teleflex
-2.72%-4.78%-11.88%-4.48%-0.10%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
+1.17%+3.63%+6.39%+8.23%+49.66%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
2.50
Moderate Buy$36.004.01% Upside
Omnicell, Inc. stock logo
OMCL
Omnicell
2.78
Moderate Buy$57.8675.17% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.42
Hold$152.9027.25% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.86
Moderate Buy$382.002.00% Upside

Current Analyst Ratings Breakdown

Latest OMCL, AMN, WST, and TFX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/22/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UpgradeEqual Weight ➝ Overweight$365.00 ➝ $400.00
9/21/2026
Teleflex Incorporated stock logo
TFX
Teleflex
Reiterated RatingSell (D)
9/18/2026
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
UpgradeSell (D+) ➝ Hold (C-)
9/11/2026
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
Boost Price TargetOutperform$38.00 ➝ $40.00
9/9/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Boost Price TargetBuy$340.00 ➝ $415.00
9/7/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
UpgradeStrong Sell ➝ Hold
8/25/2026
Teleflex Incorporated stock logo
TFX
Teleflex
Boost Price TargetBuy$159.00 ➝ $170.00
8/24/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
Reiterated RatingOverweight
8/18/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
UpgradeHold (C-) ➝ Hold (C)
8/14/2026
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
Reiterated RatingOutperform
8/14/2026
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
Boost Price TargetMarket Outperform$36.00 ➝ $40.00
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
$2.73B0.49$8.32 per share4.16$16.72 per share2.07
Omnicell, Inc. stock logo
OMCL
Omnicell
$1.18B1.27$2.75 per share11.99$27.45 per share1.20
Teleflex Incorporated stock logo
TFX
Teleflex
$1.99B2.55$10.77 per share11.16$70.71 per share1.70
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$3.07B8.57$9.83 per share38.11$44.10 per share8.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
-$95.70M$2.6812.9231.181.193.06%19.92%5.93%11/5/2026 (Estimated)
Omnicell, Inc. stock logo
OMCL
Omnicell
$2.05M$0.8439.3232.070.833.13%5.66%3.57%10/29/2026 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
-$905.64M-$23.29N/A10.950.83-39.67%11.93%5.44%11/5/2026 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$493.70M$7.8147.9537.832.6016.98%20.11%14.83%10/22/2026 (Estimated)

Latest OMCL, AMN, WST, and TFX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/22/2026Q3 2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.19N/AN/AN/A$825.98 millionN/A
8/6/2026Q2 2026
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
$0.1888$0.77+$0.5812$0.53$628.39 million$673.24 million
8/6/2026Q2 2026
Teleflex Incorporated stock logo
TFX
Teleflex
$1.28$1.76+$0.48$2.28$559.59 million$570.33 million
7/30/2026Q2 2026
Omnicell, Inc. stock logo
OMCL
Omnicell
$0.4675$0.94+$0.4725$0.52$310.21 million$312.21 million
7/23/2026Q2 2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.08$2.37+$0.29$2.15$839.98 million$872.30 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
N/AN/AN/AN/AN/A
Omnicell, Inc. stock logo
OMCL
Omnicell
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.361.13%N/AN/A N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.880.23%+5.51%11.27%N/A

Latest OMCL, AMN, WST, and TFX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2026
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.340.99%8/14/20268/14/20269/30/2026
7/21/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.220.26%7/29/20267/29/20268/5/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
1.00
1.13
1.13
Omnicell, Inc. stock logo
OMCL
Omnicell
0.13
1.64
1.43
Teleflex Incorporated stock logo
TFX
Teleflex
0.94
2.60
2.12
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.07
2.82
2.12

Institutional Ownership

CompanyInstitutional Ownership
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
99.23%
Omnicell, Inc. stock logo
OMCL
Omnicell
97.70%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
1.07%
Omnicell, Inc. stock logo
OMCL
Omnicell
2.92%
Teleflex Incorporated stock logo
TFX
Teleflex
0.70%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
2,66438.73 million38.32 millionOptionable
Omnicell, Inc. stock logo
OMCL
Omnicell
3,58045.48 million44.15 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
15,50042.37 million42.08 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,80070.38 million69.95 millionOptionable

Recent News About These Companies

West Pharmaceutical Services, Inc.
Is West Pharmaceutical Services Stock Outperforming the Nasdaq?
West Pharmaceutical Services (NYSE:WST) VP Sells 2,500 Shares

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMN Healthcare Services stock logo

AMN Healthcare Services NYSE:AMN

$34.61 +0.70 (+2.07%)
Closing price 03:59 PM Eastern
Extended Trading
$34.57 -0.04 (-0.12%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

Omnicell stock logo

Omnicell NASDAQ:OMCL

$33.03 +0.04 (+0.12%)
Closing price 04:00 PM Eastern
Extended Trading
$33.01 -0.02 (-0.06%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Teleflex stock logo

Teleflex NYSE:TFX

$120.15 -1.60 (-1.31%)
Closing price 03:59 PM Eastern
Extended Trading
$122.57 +2.42 (+2.01%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$374.51 -1.36 (-0.36%)
Closing price 03:59 PM Eastern
Extended Trading
$373.68 -0.82 (-0.22%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.